In summary, to our knowledge, our study is the first to show that BCR signaling represses S1PR1 expression and function on CLL cells, potentially leading to delayed egress from lymphoid tissues. This evidence concerns the gene S1PR1 and B-cell chronic lymphocytic leukemia.